Quick Answer
ABBOTT LABORATORIES reported Cash And Cash Equivalents At Carrying Value of $8.52 billion for the year ending 2025.
- ABBOTT LABORATORIES showed an increase of +11.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from ABBOTT LABORATORIES's annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2007 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 19 years of available data (2007 to 2025), ABBOTT LABORATORIES's Cash And Cash Equivalents At Carrying Value has grown by 246.9%.
- Historical annual values: Fiscal year 2025: $8.52 billion | Fiscal year 2024: $7.62 billion | Fiscal year 2023: $6.90 billion | Fiscal year 2022: $9.88 billion | Fiscal year 2021: $9.80 billion | Fiscal year 2020: $6.84 billion | Fiscal year 2019: $3.86 billion | Fiscal year 2018: $3.84 billion | Fiscal year 2017: $9.41 billion | Fiscal year 2016: $18.62 billion | Fiscal year 2015: $5.00 billion | Fiscal year 2014: $4.06 billion | Fiscal year 2013: $3.48 billion | Fiscal year 2012: $10.80 billion | Fiscal year 2011: $6.81 billion | Fiscal year 2010: $3.65 billion | Fiscal year 2009: $8.81 billion | Fiscal year 2008: $4.11 billion | Fiscal year 2007: $2.46 billion.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: